Daclatasvir
| CAS No. | 1009119-64-5 |
|---|---|
| MDL No. | MFCD17129086 |
| MF | C40H50N8O6 |
| MW | 738.90 |
| InChI Key | FKRSSPOQAMALKA-CUPIEXAXSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Daclatasvir is a biphenyl compound and a potent inhibitor of nonstructural protein 5A, used as its hydrochloride salt in the treatment of hepatitis C. It functions as an antiviral drug and belongs to the classes of imidazoles, carbamate esters, carboxamides, and valine derivatives. It is also a conjugate base of daclatasvir(2+).
| CAS No. | 1009119-64-5 |
|---|---|
| Product Name | Daclatasvir |
Associated Conditions
COVID-19·hepatitis B virus infection·viral disease·chronic hepatitis C virus infection·severe acute respiratory syndrome·
* The information provided here is compiled from public sources and is for reference only.
